Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FBP1 | P09467 | 1/20 | 0.59 |
| ▸ | LMNA | P02545 | 1/20 | 0.55 |
| ▸ | GBA1 | P04062 | 1/20 | 0.55 |
| ▸ | IGF2R | P11717 | 4/20 | 0.47 |
| ▸ | ADSS2 | P30520 | 1/20 | 0.44 |
| ▸ | AMDHD2 | Q9Y303 | 1/20 | 0.43 |
| ▸ | UMPS | P11172 | 5/20 | 0.42 |
| ▸ | DNPH1 | O43598 | 1/20 | 0.42 |
| ▸ | HPRT1 | P00492 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25778394 | 1.00 | FBP1 (0.59) | FBP1LMNAGBA1IGF2RADSS2 | |
| SCHEMBL2028658 | 1.00 | FBP1 (0.59) | FBP1LMNAGBA1IGF2RADSS2 | |
| SCHEMBL15670703 | 1.00 | FBP1 (0.59) | FBP1LMNAGBA1IGF2RADSS2 | |
| SCHEMBL29223798 | 0.76 | FBP1 (0.55) | FBP1IGF2RADSS2AMDHD2UMPS | |
| SCHEMBL30189347 | 0.75 | FBP1 (1.00) | FBP1IGF2RAMDHD2UMPSDNPH1 | |
| SCHEMBL20154711 | 0.75 | FBP1 (1.00) | FBP1IGF2RAMDHD2UMPSDNPH1 | |
| SCHEMBL7129042 | 0.74 | LMNA (0.56) | LMNAGBA1IGF2R | |
| SCHEMBL13997127 | 0.74 | LMNA (0.56) | LMNAGBA1IGF2R | |
| Gluconolactone SCHEMBL11053856 | 0.72 | LMNA (0.76) | FBP1LMNAGBA1 | |
| Gluconolactone SCHEMBL24637666 | 0.71 | LMNA (1.00) | LMNAGBA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1192 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260035705-A1 | ENGINEERED MICROORGANISMS WITH G3P ->3PG ENZYME AND/OR FRUCTOSE-1,6-BISPHOSPHATASE INCLUDING THOSE HAVING SYNTHETIC OR ENHANCED METHYLOTROPHY | AGAIN BIO APS (DK) | 2026-02-05 | — | — | US | claimed |
| US-12471814-B2 | Analyte sensors and methods of use thereof | ABBOTT DIABETES CARE INC. (US) | 2025-11-18 | — | — | US | claimed |
| EP-4555324-A1 | DETERMINATION OF HEMATOCRIT | IDEXX Laboratories, Inc. (US) | 2025-05-21 | — | — | EP | claimed |
| WO-2025072741-A1 | PRESERVATIVES FOR MOLECULAR SAMPLE ANALYSIS WITH SAMPLE COLLECTION DEVICES | BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) | 2025-04-03 | — | — | WO | claimed |
| CN-112752840-B | Microorganism and method for producing glycolic acid from pentoses and hexoses | 图卢兹国家应用科学研究院 | 2024-11-12 | — | — | CN | claimed |
| US-20240053367-A1 | Determination of Hematocrit | IDEXX LABORATORIES, INC. | 2024-02-15 | — | — | US | claimed |
| WO-2024015624-A1 | DETERMINATION OF HEMATOCRIT | IDEXX LABORATORIES, INC. (US) | 2024-01-18 | — | — | WO | claimed |
| US-11851696-B2 | Microorganisms and process for producing glycolic acid from pentoses and hexoses | Institut National des Sciences Appliquées de Toulouse (FR) | 2023-12-26 | — | — | US | claimed |
| EP-4271826-A1 | ANALYTE SENSORS AND METHODS OF USE THEREOF | Abbott Diabetes Care, Inc. (US) | 2023-11-08 | — | — | EP | claimed |
| CN-116917494-A | Analyte sensor and method of using same | 美国雅培糖尿病护理公司 | 2023-10-20 | — | — | CN | claimed |
| EP-1164199-A1 | ENZYMATIC FLUORIMETRIC ASSAY OF cAMP AND ADENYLATE CYCLASE | FUSO PHARMACEUTICAL INDUSTRIES LTD. (JP) | 2001-12-19 | — | — | EP | claimed |
| US-6033890-A | Homogeneous immunoassays using mutant glucose-6-phosphate dehydrogenases | BEHRING DIAGNOSTICS GMBH (DE) | 2000-03-07 | — | — | US | claimed |
| EP-0639646-B1 | HIGH PRECISION DETERMINATION OF D-GLUCOSE-6-PHOSPHATE AND COMPOSITION THEREFOR | ASAHI CHEMICAL IND (JP) | 1998-05-06 | — | — | EP | claimed |
| US-5618665-A | PRETREATMENT WITH ENZYMES TO ELIMINATE OTHER NUCLEOTIDES | REGENTS OF THE UNIVERSITY OF MINNESOTA (US) | 1997-04-08 | — | — | US | claimed |
| EP-0474116-B1 | Stable 6-phosphogluconolactonase, method of its production and its use | BOEHRINGER MANNHEIM GMBH (DE) | 1995-07-26 | — | — | EP | claimed |
| US-5426034-A | Culturing microorganism leuconostoc, lysing, precipitating 6-phosphogluconolactonase, purification by chromatography | BOEHRINGER MANNHEIM GMBH (DE) | 1995-06-20 | — | — | US | claimed |
| EP-0639646-A1 | HIGH PRECISION DETERMINATION OF D-GLUCOSE-6-PHOSPHATE AND COMPOSITION THEREFOR | ASAHI KASEI KOGYO KABUSHIKI KAISHA (JP) | 1995-02-22 | — | — | EP | claimed |
| WO-1994017198-A1 | ENZYMATIC FLUOROMETRIC ASSAY FOR ADENYLATE CYCLASE | REGENTS OF THE UNIVERSITY OF MINNESOTA (US) | 1994-08-04 | — | — | WO | claimed |
| US-5316907-A | Enzymatic fluorometric assay for adenylate cyclase | REGENTS OF THE UNIVERSITY OF MINNESOTA (US) | 1994-05-31 | — | — | US | claimed |
| US-4778755-A | CONVERTING SUBSTRATE TO PHOTOMETRICALLY DETECTABLE COMPOUND WITH ENZYME, TERMINATING REACTION WITH SECOND PRODUCT | MINNESOTA MINING AND MANUFACTURING COMPANY (US) | 1988-10-18 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260035705-A1 | ENGINEERED MICROORGANISMS WITH G3P ->3PG ENZYME AND/OR FRUCTOSE-1,6-BISPHOSPHATASE INCLUDING THOSE HAVING SYNTHETIC OR ENHANCED METHYLOTROPHY | ME1, FBP1, ME3 | FBP1 2/4885LMNA 3096/4885GBA1 3328/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.